Updated July 2026 · 8 min read

Milrinone: The ICU Nurse's Guide

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Milrinone is dobutamine's quieter, longer-acting cousin — an inotrope that also dilates. It's a favorite in decompensated heart failure and right-heart failure because it improves contractility while dropping the resistance the ventricle pumps against. But it clears through the kidneys, has a long half-life, and drops blood pressure, which makes it a drug the bedside nurse has to respect over hours, not minutes.

What milrinone is and how it works

Milrinone inhibits phosphodiesterase-3 (PDE-3), raising intracellular cyclic AMP in heart and vascular smooth muscle. In the heart that increases contractility (positive inotropy) and relaxation; in the vasculature it causes dilation, lowering both systemic afterload and — importantly — pulmonary vascular resistance. Because it works downstream of the beta receptor, it keeps working even when beta receptors are downregulated or blocked, which is a real advantage in chronic heart failure patients already on beta-blockers.

That combination — squeeze harder, dilate the circuit — is why it's called an "inodilator" and why it shines in right ventricular failure and pulmonary hypertension, where unloading the pulmonary bed matters as much as inotropy.

Dosing and the renal caveat

The single most important nursing point: milrinone accumulates in renal impairment. A catecholamine like dobutamine washes out in minutes when you turn it off; milrinone lingers for hours, and longer if the kidneys are failing. That means hypotension you cause by titrating up won't quickly reverse when you titrate down.

The side effects that matter at the bedside

Hypotension. The dominant concern, driven by systemic vasodilation. Many ICU patients on milrinone also run a pressor like norepinephrine to hold the MAP while milrinone unloads and pumps.

Arrhythmias. Ventricular and atrial arrhythmias occur, though often with less tachycardia than dobutamine.

Accumulation in renal failure. Watch for prolonged, deepening hypotension in patients whose creatinine is climbing.

Milrinone vs. dobutamine — the bedside comparison

Both improve output, but they're not interchangeable. Dobutamine is a beta-1 catecholamine: faster on and off, more tachycardia, blunted by beta-blockers. Milrinone works past the beta receptor, unloads the pulmonary circuit better, causes more sustained hypotension, and clears renally. In a beta-blocked chronic-heart-failure patient or a failing right ventricle, milrinone often wins; when you need quick titratability, dobutamine has the edge.

Bottom line

Milrinone is the inodilator: it strengthens the pump while dilating both circulations, making it a workhorse in decompensated and right-heart failure. Respect its three defining features — hypotension, a long half-life, and renal accumulation — and understand why it so often runs beside a pressor. Master the flow-versus-tone thinking at the ICU bedside and it becomes second nature in anesthesia.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.